Dr Philip Day (PhD, FSB, FRSC) - personal details
Philip Day is Reader in Quantitative Analytical Genomics at Manchester University, and is Director of the Quantitative Molecular Medicine Group at the Manchester Interdisciplinary Biocentre, where he also oversees the operation of a transcriptomics facility for CIGMR, the Medical Faculty. During 1990 to 1995 he established The Molecular Oncology Prognostic and Research Laboratories at the Birmingham Children’s Hospital.
Between 1995 and 1997 he worked on the Human Genome Mapping Project at the Wellcome Trust Centre for Complex Diseases, Oxford, (with M. Lathrop and M.R. James) developing high throughput mapping procedures and instrumentation. In 1997 he joined the Department of Biochemistry, Oxford (with Sir E.M. Southern), where he contributed to a very high throughput sequence analysis study utilising hybridisation and mass spectrometry. Dr Day has always maintained a close interest with the production of new and innovative tools for applied quantitative molecular biology, and more recent research programmes have developed interests in miniaturisation for single cell studies. He has a firm belief that units of biologically meaningful data should be presented as molecules per cell. He is developing procedures to enable quantitative data measurements for the implementation of predictive systems biology modeling. This work has produced patent applications related to gene quantification. For over many years he has developed specialist knowledge in the paediatric cancer neuroblastoma. He is active in several other applied research areas related to transcriptomics and aneuploidy, including interests in integrated miniaturisation for micro total analysis. He has over 90 peer reviewed papers and presently supervises 7 PhD degree students.
Between 1998 and 2002 he founded and headed the Functional Genomics Unit, Childrens’ University Hospital Zurich. In 2002 he moved to the Medical School, University of Manchester and became Director of Operations for CIGMR. He was invited in March 2006 to move his group to the Manchester Interdisciplinary Biocentre (MIB), where he is Principal Investigator, and continues developing applied quantitative measurement in relation to disease progression by working closely with groups in systems biology, analytical instrumentation, miniaturisation and text mining. He is a member of the MIB Council, and serves as an examiner for UK granting bodies, a FP7 EU expert examiner, external examiner for biological sciences degree schemes, University of Cardiff, and is an editorial team member for the RSC journal Integrative Biology.
In 2004 and 2008 respectively, he was elected Fellow of the Royal Society of Chemistry and Fellow of the Society of Biology.
Memberships of Committees and Professional Bodies
Fellow of the Royal Society of Chemistry, 2004
Fellow of the Society of Biology, 2008
RSC Editorial Board
Council Member of the Manchester Institute of Biotechnology
Senior Management Team, Centre for Epidemiology
Philip received his BSc from Lancaster University and MSc and PhD degrees from the Wolfson Research laboratories, Birmingham University.